1. Home
  2. Companies
  3. Flexion Therapeutics, Inc.
  4. Financial Statements
  5. Income Statement
  6. General and Administrative Expenses
Flexion Therapeutics, Inc. logo
Flexion Therapeutics, Inc. FLXN

Flexion Therapeutics, Inc. General and Administrative Expenses 2011-2026 | FLXN

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.
What these expenses include
  • Salaries of administrative staff (executives, HR, accountants, legal personnel)
  • Office rent and utilities
  • Office equipment and IT infrastructure
  • Professional services (auditors, lawyers, consultants)
  • Insurance
  • General administrative travel and representation expenses
What the metric indicates
  • Cost control
    A high level of such expenses may indicate inefficient management or an overly complex structure
  • Profitability
    Reducing administrative expenses while maintaining stable revenue increases operating profit
  • Comparative analysis
    Investors can compare this metric as a percentage of revenue among companies in the same industry
  • Business flexibility
    Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Flexion Therapeutics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
105 M 130 M 121 M 78.8 M 28.5 M 13.4 M 9.06 M 6.7 M 3.95 M 3.05 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
130 M 3.05 M 49.9 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer General and Administrative Expenses Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		9.05 M - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		78.3 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		2.31 M - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
 		11 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		900 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		1.4 B - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
 		7.15 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
 		16.2 M - 2.54 % $ 160 B franceFrance
AstraZeneca PLC AstraZeneca PLC
AZN
 		19.9 B - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		4.66 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		16.7 M - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		24.5 M - 0.74 % $ 768 M israelIsrael
Galera Therapeutics Galera Therapeutics
GRTX
 		5.69 M - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		4.95 M - -18.52 % $ 27.3 M britainBritain
Esperion Therapeutics Esperion Therapeutics
ESPR
 		166 M $ 3.14 0.16 % $ 653 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
 		35.8 M $ 34.42 4.65 % $ 926 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
 		12.4 M $ 20.35 1.4 % $ 263 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		25.8 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		15.7 M - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		10.5 M - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		95.1 M - -7.31 % $ 87 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
 		46.1 M $ 6.84 2.17 % $ 187 M israelIsrael
Grifols, S.A. Grifols, S.A.
GRFS
 		1.26 B $ 8.21 4.72 % $ 5.58 B spainSpain
Generation Bio Co. Generation Bio Co.
GBIO
 		37.8 M - - $ 344 M usaUSA
IMV IMV
IMV
 		17 M - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		37.9 M - - $ 3.67 B usaUSA
BioNTech SE BioNTech SE
BNTX
 		514 M $ 90.48 3.06 % $ 21.9 B germanyGermany
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		132 M $ 1.64 0.61 % $ 436 M britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		1.53 M - - $ 7.46 M israelIsrael
Heron Therapeutics Heron Therapeutics
HRTX
 		54.6 M $ 0.85 0.57 % $ 142 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		7.72 M - -4.36 % $ 27 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
 		8.89 M $ 2.74 0.18 % $ 256 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
 		49.1 M $ 15.15 2.23 % $ 217 M usaUSA
Advaxis Advaxis
ADXS
 		12.2 M - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		10.1 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		47.9 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		100 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		17 M - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		3.66 M $ 3.39 4.17 % $ 5.58 M israelIsrael
AIkido Pharma AIkido Pharma
AIKI
 		23.8 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		13.4 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
 		19.8 M - -39.0 % $ 4.57 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
 		101 M $ 1.52 2.7 % $ 178 M usaUSA
Akouos Akouos
AKUS
 		22.2 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		69.6 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
 		11 M - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
 		38.8 M - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		275 M $ 20.45 4.9 % $ 2.6 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		12.7 M - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		7.08 M - -11.43 % $ 502 K usaUSA